• LANGUAGE
    • German
    • Russian
  • SEARCH
  • CONTACT US
  • WORLDWIDE

Golrang Pharmaceutical Investment CoGolrang Pharmaceutical Investment CoGolrang Pharmaceutical Investment Co

  • ABOUT US
    • Our History
      • GPI
      • GIG as Mother Company
    • Our Business
      • Priorities
      • GPI Foreign Companies
      • Key Facts & Figures
      • Disease Areas
    • Our Advantages
    • Our Companies
      • Varian Pharmed
      • Faran Shimi
      • Hasti Aria Shimi
      • Arian Salamat Sina
      • Salamat Pakhsh Hasti
      • Abian Daru
    • Our Governance
      • Board Of Directors
      • Annual General Meeting
      • Executive Committees
    • Our People
      • Meet The CEO
  • PRODUCTS
    • APIs
      • Narcotic
      • Endothelin Receptor Antagonist
      • Anti-Inflammatory Agent
      • Anti-Asthma
      • Anti-Convulsant
    • FDFs
      • Oncology
      • Painkillers
      • Anti-Addiction
      • HBP
      • Dialysis Solution
      • Antitussive
      • Statins
    • Nutrition Supplements
  • SUSTAINABILITY
    • How We Work
      • Our Approach
      • Our Commitment
      • Our Strategy
    • What We Do
      • For Patients
      • For Employees
      • For Environment
  • R&D
    • Pipeline
    • Our Structure
    • Ethics in R&D
    • R&D Locations
    • Research Process
    • Clinical Trials
  • PARTNERING
    • About Partnering
    • Areas Of Interest
    • Investors
    • Collaborations With Academia
    • Submit An Idea
  • NEWS
    • Press Release
    • Events
  • CAREERS
    • Job Search
    • Working At GPI
    • Your Future Workplace
  • o4
  • o3
  • o6
  • o2
  • o1
  • ABOUT US
    • Our History
      • GPI
      • GIG as Mother Company
    • جدا کننده متن
    • Our Business
      • Priorities
      • GPI Foreign Companies
      • Key Facts & Figures
      • Disease Areas
    • Our Advantages
    • Our Companies
      • Varian Pharmed
      • Faran Shimi
      • Hasti Aria Shimi
      • Arian Salamat Sina
      • Salamat Pakhsh Hasti
      • Abian Daru
    • Our Governance
      • Board Of Directors
      • Annual General Meeting
      • Executive Committees
    • Our People
      • Meet The CEO
  • PRODUCTS
    • APIs
      • Narcotic
      • Endothelin Receptor Antagonist
      • Anti-Inflammatory Agent
      • Anti-Asthma
      • Anti-Convulsant
    • FDFs
      • Oncology
      • Painkillers
      • Anti-Addiction
      • HBP
      • Dialysis Solution
      • Antitussive
      • Statins
    • Nutrition Supplements
  • SUSTAINABILITY
    • How We Work
      • Our Approach
      • Our Commitment
      • Our Strategy
    • What We Do
      • For Patients
      • For Employees
      • For Environment
  • R&D
    • Pipeline
    • Our Structure
    • Ethics in R&D
    • R&D Locations
    • Research Process
    • Clinical Trials
  • PARTNERING
    • About Partnering
    • Areas Of Interest
    • Investors
    • Collaborations With Academia
    • Submit An Idea
  • NEWS
    • Press Release
    • Events
  • CAREERS
    • Job Search
    • Working At GPI
    • Your Future Workplace

OTHER GOLRANG SITES

www.Varianpharmed.com

www.Faranshimi.com

www.Hastiaria.com

www.Ariansalamat.com

www.Salamatpakhsh.com

www.Abiandarou.com

www.Abianpharmed.com

SOCIAL @ GOLRANG

 

A member of Golrang Industrial Group

www.golrang.com

LATEST NEWS

We are glad to exhibit in Iran Pharma 2017, a successful step forward in Iranian and world market 12 September 2017
Mr. Kaiser Waheed, the chairman of Pakistan Pharmaceutical Manufacturers` Association (PPMA) visited GPI headquarter in Tehran. 08 Aug 2017 08 August 2017
GPI deligation will attend at Pharmatech; 18th International Exhibition, Moscow, Russia (22-25 Nov.2016) 16 November 2016

Copyright © 2016 GPI(Golrang Pharmaceutical Investment Co.). All rights reserved

Link RSS | Legal Notice | Terms Of Use | Privacy Policy | Site Map

OTHER GOLRANG SITES

www.Varianpharmed.com

www.Faranshimi.com

www.Hastiaria.com

www.Ariansalamat.com

www.Salamatpakhsh.com

www.Abiandarou.com

www.Abianpharmed.com

SOCIAL @ GOLRANG

 

A member of Golrang Industrial Group

www.golrang.com

LATEST NEWS

We are glad to exhibit in Iran Pharma 2017, a successful step forward in Iranian and world market 12 September 2017
Mr. Kaiser Waheed, the chairman of Pakistan Pharmaceutical Manufacturers` Association (PPMA) visited GPI headquarter in Tehran. 08 Aug 2017 08 August 2017
GPI deligation will attend at Pharmatech; 18th International Exhibition, Moscow, Russia (22-25 Nov.2016) 16 November 2016

Copyright © 2016 GPI(Golrang Pharmaceutical Investment Co.). All rights reserved

Link RSS | Legal Notice | Terms Of Use | Privacy Policy | Site Map